AMGEN - BIOFARMACEUTICA, LDA. secures contract for Acquisition Of Evolocumab Sc 140 Mg/Ml Ser Sol Inj, Under Cpa 2025/1627, For Ulsasi, For The Year 2026

Portugal, April 1 -- Portugal based AMGEN - BIOFARMACEUTICA, LDA. has secured contract from Unidade Local De Saude Amadora/Sintra, E.P.E. for Acquisition Of Evolocumab Sc 140 Mg/Ml Ser Sol Inj, Under Cpa 2025/1627, For Ulsasi, For The Year 2026. The value of the contract is worth 2122080 EUR.

Published by HT Digital Content Services with permission from Pivotal Sources....